"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
TO ARTICLE
METRICS

Review article
peer-reviewed

Treatments for Primary Immune Thrombocytopenia: A Review


Total Article Reads

Article reads consist of online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Total Article Reads Cureus PMC
7,346 Article Views 1,904 3,947
PDF Downloads 368 1,127
Total Article Reads Cureus PMC
7,346 Article Views 1,904 3,947
PDF Downloads 368 1,127
Total Article Reads
7,346
Cureus PMC
Article Views 1,904 3,947
PDF Downloads 368 1,127

Article Reads by Date

Hover your cursor over a specific day or month to see the corresponding online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Cureus Article Reads

Loading...

Cumulative Cureus and PMC Article Reads

Loading...

Article Reads by Country

Hover your cursor over a country to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank Country Views Percentage

Article Reads by U.S. States

Hover your cursor over a state to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank State Views Percentage

Citations

Citation index reporting varies. Crossref citations are listed below and Google Scholar citations can be seen by clicking the corresponding button.

Google Scholar  
Crossref Citations (6)
  1. Bonasia, C. G., Abdulahad, W. H., Rutgers, A., Heeringa, P., & Bos, N. A. (2021). B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells. Cells, 10(5), 1190. doi:10.3390/cells10051190.
  2. Gupta, A., Karki, R., Dandu, H. R., Dhama, K., Bhatt, M. L., & Saxena, S. K. (2020). COVID-19: benefits and risks of passive immunotherapeutics. Human Vaccines & Immunotherapeutics, 1–10. doi:10.1080/21645515.2020.1808410.
  3. Khodashahi, R., Naderi, H., Sedaghat, A., Allahyari, A., Sarjamee, S., Eshaghi, S., … Khodashahi, M. (2021). Intravenous Immunoglobulin for Treatment of Patients with COVID-19: A Case-control Study. Archives of Clinical Infectious Diseases, 16(1). doi:10.5812/archcid.108068.
  4. Di Paola, A., Palumbo, G., Merli, P., Argenziano, M., Tortora, C., Strocchio, L., … Rossi, F. (2020). Effects of Eltrombopag on In Vitro Macrophage Polarization in Pediatric Immune Thrombocytopenia. International Journal of Molecular Sciences, 22(1), 97. doi:10.3390/ijms22010097.
  5. AKSAKAL, Ş., ÖZATLI, D., TURGUT, M., & GULER, N. (2020). Retrospective Analysis of Patients with Immune Thrombocytopenic Purpura. Journal of Contemporary Medicine. doi:10.16899/jcm.734474.
  6. Jawhara, S. (2020). Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? International Journal of Molecular Sciences, 21(7), 2272. doi:10.3390/ijms21072272.

Article Research Metrics

We’ve partnered with Plum Analytics to track and display research metrics for each article. (All data provided by PlumX Metrics.) Click here to learn more about Plum Analytics.